SCHEMBL26418711

SCHEMBL26418711

N#Cc1ccc(-c2ccc(OCCCCCOC(=O)c3ccc(-c4ccc(OCCCCCOc5ccc(-c6ccc(C#N)cc6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.61
HDAC2 Q92769 1/20 0.61
MMP3 P08254 5/20 0.59
MMP2 P08253 6/20 0.58
ALDH1A1 P00352 2/20 0.56
MAPT P10636 1/20 0.56
MMP1 P03956 1/20 0.55
MMP9 P14780 1/20 0.55
MMP13 P45452 1/20 0.55
RARB P10826 3/20 0.50
HRH2 P25021 2/20 0.49
HRH1 P35367 2/20 0.49
HRH3 Q9Y5N1 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
GAA P10253 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1874571 0.95 HDAC1 (0.56) HDAC1HDAC2MMP3MMP2ALDH1A1
Phenol SCHEMBL1877890 0.90 MMP2 (0.52) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL29321625 0.84 ALDH1A1 (0.49) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL29316111 0.84 ALDH1A1 (0.49) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL21078349 0.83 HTT (0.55) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL12676172 0.83 HDAC1 (0.50) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL8621621 0.83 NPC1 (0.63) HDAC1HDAC2MMP3ALDH1A1MAPT
SCHEMBL10054731 0.83 MMP2 (0.52) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL2993045 0.83 HRH2 (0.56) HDAC1HDAC2MMP3MMP2ALDH1A1
SCHEMBL3434932 0.83 NPC1 (0.63) HDAC1HDAC2MMP3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11781070-B2 Mesogen compounds TRANSITIONS OPTICAL, LTD. (IE) 2023-10-10 US disclosed
US-11781070-B2 Mesogen compounds TRANSITIONS OPTICAL, LTD. (IE) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11781070-B2 Mesogen compounds MDN1, LSG1, MNS1 HDAC1 3686/4885HDAC2 4337/4885MMP3 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.